Copyright Reports & Markets. All rights reserved.

Global Female Infertility Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Female Infertility Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Parenteral
      • 1.4.3 Oral
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Female Infertility Drugs Market Share by Application (2019-2025)
      • 1.5.2 Ovarian Hyperstimulation Syndrome
      • 1.5.3 Multiple-gestation Pregnancies
      • 1.5.4 Multiple-birth Infants
      • 1.5.5 Premature Labor
      • 1.5.6 Low Birth Weight
      • 1.5.7 Risk of Cesarean Delivery
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Female Infertility Drugs Market Size
    • 2.2 Female Infertility Drugs Growth Trends by Regions
      • 2.2.1 Female Infertility Drugs Market Size by Regions (2019-2025)
      • 2.2.2 Female Infertility Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Female Infertility Drugs Market Size by by Players
      • 3.1.1 Global Female Infertility Drugs Revenue by by Players (2014-2019)
      • 3.1.2 Global Female Infertility Drugs Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Female Infertility Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Female Infertility Drugs Key Players Head office and Area Served
    • 3.3 Key Players Female Infertility Drugs Product/Solution/Service
    • 3.4 Date of Enter into Female Infertility Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Female Infertility Drugs Market Size by Type (2014-2019)
    • 4.2 Global Female Infertility Drugs Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Female Infertility Drugs Market Size (2014-2019)
    • 5.2 Female Infertility Drugs Key Players in North America
    • 5.3 North America Female Infertility Drugs Market Size by Type
    • 5.4 North America Female Infertility Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Female Infertility Drugs Market Size (2014-2019)
    • 6.2 Female Infertility Drugs Key Players in Europe
    • 6.3 Europe Female Infertility Drugs Market Size by Type
    • 6.4 Europe Female Infertility Drugs Market Size by Application

    7 China

    • 7.1 China Female Infertility Drugs Market Size (2014-2019)
    • 7.2 Female Infertility Drugs Key Players in China
    • 7.3 China Female Infertility Drugs Market Size by Type
    • 7.4 China Female Infertility Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Female Infertility Drugs Market Size (2014-2019)
    • 8.2 Female Infertility Drugs Key Players in Japan
    • 8.3 Japan Female Infertility Drugs Market Size by Type
    • 8.4 Japan Female Infertility Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Female Infertility Drugs Market Size (2014-2019)
    • 9.2 Female Infertility Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Female Infertility Drugs Market Size by Type
    • 9.4 Southeast Asia Female Infertility Drugs Market Size by Application

    10 India

    • 10.1 India Female Infertility Drugs Market Size (2014-2019)
    • 10.2 Female Infertility Drugs Key Players in India
    • 10.3 India Female Infertility Drugs Market Size by Type
    • 10.4 India Female Infertility Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Female Infertility Drugs Market Size (2014-2019)
    • 11.2 Female Infertility Drugs Key Players in Central & South America
    • 11.3 Central & South America Female Infertility Drugs Market Size by Type
    • 11.4 Central & South America Female Infertility Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Allergan Plc
      • 12.1.1 Allergan Plc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Female Infertility Drugs Introduction
      • 12.1.4 Allergan Plc Revenue in Female Infertility Drugs Business (2014-2019))
      • 12.1.5 Allergan Plc Recent Development
    • 12.2 Ferring BV
      • 12.2.1 Ferring BV Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Female Infertility Drugs Introduction
      • 12.2.4 Ferring BV Revenue in Female Infertility Drugs Business (2014-2019)
      • 12.2.5 Ferring BV Recent Development
    • 12.3 Merck KGaA
      • 12.3.1 Merck KGaA Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Female Infertility Drugs Introduction
      • 12.3.4 Merck KGaA Revenue in Female Infertility Drugs Business (2014-2019)
      • 12.3.5 Merck KGaA Recent Development
    • 12.4 Novartis AG
      • 12.4.1 Novartis AG Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Female Infertility Drugs Introduction
      • 12.4.4 Novartis AG Revenue in Female Infertility Drugs Business (2014-2019)
      • 12.4.5 Novartis AG Recent Development
    • 12.5 Sanofi
      • 12.5.1 Sanofi Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Female Infertility Drugs Introduction
      • 12.5.4 Sanofi Revenue in Female Infertility Drugs Business (2014-2019)
      • 12.5.5 Sanofi Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Female infertility refers to infertility in women. It affects an estimated 48 million women,with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia.
      The adverse effects and high cost of non-therapeutics will also boost the popularity of female infertility drugs. Various ART procedures, including IVF, IUI, and ICSI are available as alternatives to medications for the treatment of female infertility.
      In 2018, the global Female Infertility Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Female Infertility Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Female Infertility Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Allergan Plc
      Ferring BV
      Merck KGaA
      Novartis AG
      Sanofi
      ...

      Market segment by Type, the product can be split into
      Parenteral
      Oral
      Others

      Market segment by Application, split into
      Ovarian Hyperstimulation Syndrome
      Multiple-gestation Pregnancies
      Multiple-birth Infants
      Premature Labor
      Low Birth Weight
      Risk of Cesarean Delivery

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Female Infertility Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Female Infertility Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Female Infertility Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now